Trial Profile
A Study to Assess Safety of Current Standard Malaria Treatment and an Assessment of Glucose-6-dehydrogenase Status in South-east Bangladesh
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 May 2022
Price :
$35
*
At a glance
- Drugs Artemether/lumefantrine (Primary) ; Primaquine
- Indications Malaria
- Focus Adverse reactions
- 09 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Mar 2015 New trial record